Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Summary

The purpose of this study is to evaluate the potential of DFD-06 to suppress the hypothalamic-pituitary-adrenal (HPA) axis when applied twice daily for 15 days.

Timeline

Start

2017-05-02

Primary completion

2019-06-03

Completion

2020-06-03

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty in enrollment”

Drugs

Indications